AZILECT

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Germany, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Mexico, Netherlands, Poland, Romania, Singapore, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug AZILECT contains one active pharmaceutical ingredient (API):

1 Rasagiline UNII LH8C2JI290 - RASAGILINE MESYLATE

Rasagiline was shown to be a potent, irreversible MAO-B selective inhibitor, which may cause an increase in extracellular levels of dopamine in the striatum. The elevated dopamine level and subsequent increased dopaminergic activity are likely to mediate rasagiline’s beneficial effects seen in models of dopaminergic motor dysfunction. Read about Rasagiline

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N04BD02	Rasagiline	N Nervous system → N04 Anti-parkinson drugs → N04B Dopaminergic agents → N04BD Monoamine oxidase B inhibitors
Discover more medicines within N04BD02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 1952R
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 537500802115219, 537517110007003
Country: CA	Health Products and Food Branch	Identifier(s): 02284642, 02284650
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00275748, 00285758, 00559641, 01686910, 03103189, 03104409, 03442744, 03887251, 03887274, 05351833, 05500500, 05500517, 07264920, 07337576, 07337582, 09695340, 09695357, 10060925, 10167586, 10201610, 10989578, 10989584, 12146097, 12368745, 14178411, 15612476, 16151190
Country: EE	Ravimiamet	Identifier(s): 1203400, 1203411, 1203422, 1203433, 1203444, 1203455
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 04304004, 04304004IP1, 04304004IP2, 04304004IP3, 04304004IP4, 04304004IP5
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 084406
Country: FR	Base de données publique des médicaments	Identifier(s): 62722988
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 374303, 376213, 381189, 93627
Country: HK	Department of Health Drug Office	Identifier(s): 60594
Country: IE	Health Products Regulatory Authority	Identifier(s): 13115, 13166, 31802, 31808
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 4803
Country: IT	Agenzia del Farmaco	Identifier(s): 036983029
Country: JP	医薬品医療機器総合機構	Identifier(s): 1169017F1025, 1169017F2021
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1005647, 1026350, 1026351, 1026353, 1026354, 1026355, 1026356
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 156M2006
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 78891
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100105492
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W62982001, W62982002, W62982003, W62982004, W62982006, W62982008, W62982009
Country: SG	Health Sciences Authority	Identifier(s): 15291P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699638015313, 8699638015450
Country: US	FDA, National Drug Code	Identifier(s): 68546-142, 68546-229
Country: ZA	Health Products Regulatory Authority	Identifier(s): 41/5.4.1/0781